EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses
Finn Sellebjerg(Danish Multiple Sclerosis Center), Per Soelberg Sørensen(University of Copenhagen), Leo H. Visser, Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), Krzysztof Selmaj(University of Warmia and Mazury in Olsztyn), Rune Midgard(Norwegian University of Science and Technology), David Barnes(Atkins (United Kingdom)), Graziella Filippini(Oldham Council)
Cited by 142
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k